Kiso Tetsuo | Neuroscience Research Pharmacology Laboratories Institute For Drug Discovery Research Yamanouchi Pha
スポンサーリンク
概要
- KISO Tetsuoの詳細を見る
- 同名の論文著者
- Neuroscience Research Pharmacology Laboratories Institute For Drug Discovery Research Yamanouchi Phaの論文著者
関連著者
-
Kiso Tetsuo
Neuroscience Research Pharmacology Laboratories Institute For Drug Discovery Research Yamanouchi Pha
-
Kiso Tetsuo
Neuroscience Research Pharmacological Laboratories Institute For Drug Discovery Research Yamanouchi
-
Miyata Keiji
Neuroscience/gastrointestinal Research Laboratories Institute For Drug Discovery Research Yamanouchi
-
Miyata Keiji
Neuroscience And Gastrointestinal Research Laboratory Institute For Drug Discovery Research Yamanouc
-
ITO Hiroyuki
Neuroscience Research, Pharmacology Laboratories, Institute for Drug Discovery Research, Yamanouchi
-
Miyata Keiji
Neuroscience Research Pharmacological Laboratories Institute For Drug Discovery Research Yamanouchi
-
NAGAKURA Yukinori
Neuroscience Research, Pharmacological Laboratories, Institute for Drug Discovery Research, Yamanouc
-
NAITOH Yuki
Neuroscience Research, Pharmacological Laboratories, Institute for Drug Discovery Research, Yamanouc
-
Nagakura Yukinori
Neuroscience Research Pharmacological Laboratories Institute For Drug Discovery Research Yamanouchi
-
Naitoh Yuki
Neuroscience Research Pharmacological Laboratories Institute For Drug Discovery Research Yamanouchi
-
Ito Hiroyuki
Neuroscience And Gastrointestinal Research Laboratory Institute For Drug Discovery Research Yamanouc
-
Ito Hiroyuki
Neuroscience Research Pharmacological Laboratories Institute For Drug Discovery Research Yamanouchi
-
Miyata Keiji
Neuroscience & Gastrointestinal Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
著作論文
- The Selective 5 : Hydroxytryptamine (5 : HT)_4 : Receptor Agonist RS67506 Enhances Lower Intestinal Propulsion in Mice
- Role of the 5-hydroxytryptamine_3 receptor in the regulation of lower gastrointestinal function : A study mainly using novel 5-HT_3 receptor agonist